These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24501242)

  • 1. Gusperimus: immunological mechanism and clinical applications.
    Perenyei M; Jayne DR; Floßmann O
    Rheumatology (Oxford); 2014 Oct; 53(10):1732-41. PubMed ID: 24501242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive mechanisms and action of deoxyspergualin in experimental and clinical studies. Japanese Collaborative Transplant Study Group of NKT-01.
    Amemiya H
    Transplant Proc; 1995 Feb; 27(1):31-2. PubMed ID: 7879015
    [No Abstract]   [Full Text] [Related]  

  • 3. L23. Renal transplantation in ANCA-associated vasculitis.
    Segelmark M
    Presse Med; 2013 Apr; 42(4 Pt 2):568-71. PubMed ID: 23453993
    [No Abstract]   [Full Text] [Related]  

  • 4. Establishment of rejection therapy with deoxyspergualin by multicentral controlled clinical studies in renal recipients.
    Amemiya H; Taguchi Y; Fukao K; Isono K; Omoto R; Ota K; Kosaki M; Takagi H; Oka T; Sonoda T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):730-3. PubMed ID: 8438462
    [No Abstract]   [Full Text] [Related]  

  • 5. 15-Deoxyspergualin in experimental transplant models: a review.
    Kaufman DB
    Transplant Proc; 1996 Apr; 28(2):868-70. PubMed ID: 8623440
    [No Abstract]   [Full Text] [Related]  

  • 6. 15-Deoxyspergualin: a newly developed immunosuppressive agent and its mechanism of action and clinical effect: a review. Japan Collaborative Transplant Study Group for NKT-01.
    Amemiya H
    Artif Organs; 1996 Aug; 20(8):832-5. PubMed ID: 8853792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological classification and clinical effects of kidney transplant rejection treated with 15-deoxyspergualin.
    Kyo M; Ichikawa Y; Fukunishi Y; Hanafusa T; Nagano S; Takahara S; Ishibashi M; Okuyama A; Ihara H; Fujimoto N
    Transplant Proc; 1995 Feb; 27(1):1012-3. PubMed ID: 7878780
    [No Abstract]   [Full Text] [Related]  

  • 8. Deoxyspergualin--a different and intriguing immunosuppressant.
    Tufveson G; Gannedahl G
    Transplant Proc; 1994 Oct; 26(5):3029-39. PubMed ID: 7940954
    [No Abstract]   [Full Text] [Related]  

  • 9. Deoxyspergualin: clinical experience.
    Gores PF
    Transplant Proc; 1996 Apr; 28(2):871-2. PubMed ID: 8623441
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
    Jiang H; Takahara S; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1992 Oct; 24(5):1726-9. PubMed ID: 1412813
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of 15-deoxyspergualin on renal graft rejection.
    Kozaki K; Matsuno N; Sakurai E; Tamaki I; Furuhashi K; Saito A; Yoshida M; Miyamoto K; Kozaki M
    Transplant Proc; 1994 Aug; 26(4):1903-4. PubMed ID: 8066619
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of 15-deoxyspergualin in islet xenograft rejection.
    Yoshimura A; Nakajima Y; Kanehiro H; Nakano H
    Transplant Proc; 1996 Jun; 28(3):1426-7. PubMed ID: 8658724
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients.
    Takahara S; Moutabarrik A; Kokado Y; Kameoka H; Takano Y; Zaid D; Ishibashi M; Sonoda T; Okuyama A
    Transplant Proc; 1993 Jun; 25(3):2254-8. PubMed ID: 8516891
    [No Abstract]   [Full Text] [Related]  

  • 14. Pilot evaluation of 15-deoxyspergualin for refractory acute renal transplant rejection.
    Matas AJ; Gores PF; Kelley SL; Bielefield-Skrokov M; Kinaszczuk M; Gruessner RW; Najarian JS
    Clin Transplant; 1994 Apr; 8(2 Pt 1):116-9. PubMed ID: 8019020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual presentation of C-ANCA vasculitis.
    Gavrilovski M; Kakar P; Rendle J; Lawrence E; Kee K; Sathanathan R
    QJM; 2012 Nov; 105(11):1105-7. PubMed ID: 21920993
    [No Abstract]   [Full Text] [Related]  

  • 16. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
    Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H
    Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating vasculitis with conventional immunosuppressive agents.
    Jayne D
    Cleve Clin J Med; 2012 Nov; 79 Suppl 3():S46-9. PubMed ID: 23203646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
    Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
    J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracapillary glomerulonephritis type I with the coexistence of positive anti-GBM and p-ANCA antibodies.
    Toledo Perdomo K; Ortega Salas R; Pérez-Sáez MJ; Esquivias de Motta E; Espinosa Hernández M; López Andreu M; López Rubio F; Aljama García P
    Nefrologia; 2011; 31(1):113-5. PubMed ID: 21270926
    [No Abstract]   [Full Text] [Related]  

  • 20. Outline and long-term prognosis in 15-deoxyspergualin-treated cases. Japan Collaborative Transplant Study Group of NKT-01.
    Amemiya H; Koyama I; Kyo M; Kozaki K; Yuzawa K; Sakamoto K; Kakefuda T
    Transplant Proc; 1996 Jun; 28(3):1156-8. PubMed ID: 8658608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.